CD8

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
Jingjing Duan, Yongwei Xie, Lijuan Qu, Lingxiong Wang, Shunkai Zhou, Yu Wang, Zhongyi Fan, Shengsheng Yang, Shunchang Jiao

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 100; DOI: 10.1186/s40425-018-0418-7
Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence
Katey S. S. Enfield, Spencer D. Martin, Erin A. Marshall, Sonia H. Y. Kung, Paul Gallagher, Katy Milne, Zhaoyang Chen, Brad H. Nelson, Stephen Lam, John C. English, Calum E. MacAulay, Wan L. Lam, Martial Guillaud

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 13; DOI: 10.1186/s40425-018-0488-6
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy
Sonja Althammer, Tze Heng Tan, Andreas Spitzmüller, Lorenz Rognoni, Tobias Wiestler, Thomas Herz, Moritz Widmaier, Marlon C. Rebelatto, Helene Kaplon, Diane Damotte, Marco Alifano, Scott A. Hammond, Marie-Caroline Dieu-Nosjean, Koustubh Ranade, Guenter Schmidt, Brandon W. Higgs, Keith E. Steele

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 121; DOI: 10.1186/s40425-019-0589-x
Transgenerational transfer of gene-modified T cells
Cormac Cosgrove, Emilia R. Dellacecca, Joost H. van den Berg, John B. Haanen, Michael I. Nishimura, I. Caroline Le Poole, Hans E. N. Bergmans

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 186; DOI: 10.1186/s40425-019-0657-2
PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8⁺ T lymphocytes
Jesús Ogando, María Eugenia Sáez, Javier Santos, Cristina Nuevo-Tapioles, Marta Gut, Anna Esteve-Codina, Simon Heath, Antonio González-Pérez, José M. Cuezva, Rosa Ana Lacalle, Santos Mañes

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 151; DOI: 10.1186/s40425-019-0628-7
miR-448 targets IDO1 and regulates CD8⁺ T cell response in human colon cancer
Qiong Lou, Ruixian Liu, Xiangling Yang, Weiqian Li, Lanlan Huang, Lili Wei, Huiliu Tan, Nanlin Xiang, Kawo Chan, Junxiong Chen, Huanliang Liu

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 210; DOI: 10.1186/s40425-019-0691-0
Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
Keith E. Steele, Tze Heng Tan, René Korn, Karma Dacosta, Charles Brown, Michael Kuziora, Johannes Zimmermann, Brian Laffin, Moritz Widmaier, Lorenz Rognoni, Ruben Cardenes, Katrin Schneider, Anmarie Boutrin, Philip Martin, Jiping Zha, Tobias Wiestler

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 20; DOI: 10.1186/s40425-018-0326-x
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
Fanny Ledys, Quentin Klopfenstein, Caroline Truntzer, Laurent Arnould, Julie Vincent, Leila Bengrine, Romain Remark, Romain Boidot, Sylvain Ladoire, Francois Ghiringhelli, Valentin Derangere

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 123; DOI: 10.1186/s40425-018-0438-3
GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
Nick M. Durham, Nick Holoweckyj, Randall S. MacGill, Kelly McGlinchey, Ching Ching Leow, Scott H. Robbins

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 47; DOI: 10.1186/s40425-017-0247-0
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
Sotirios P. Fortis, Michael Sofopoulos, Nectaria N. Sotiriadou, Christoforos Haritos, Christoforos K. Vaxevanis, Eleftheria A. Anastasopoulou, Nicole Janssen, Niki Arnogiannaki, Alexandros Ardavanis, Graham Pawelec, Sonia A. Perez, Constantin N. Baxevanis

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 39; DOI: 10.1186/s40425-017-0240-7

Main menu

CD8

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CD8

Pages